KDM2B and cancer: Among them, KDM2B expression was strongly and highly significantly correlated with sensitivity to the HDAC inhibitor vorinostat in the NCI-60 cancer cell lines (Pearson r = -0.51, p = 4.3 × 10–5), providing a strong support for our initial finding of this association in the CCLE-GDSC dataset.